Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users
详细信息 查看全文
- 作者：John Lewis ; Anna Molnar ; David Allsop…
- 关键词：Cannabis ; Carboxy ; THC ; THCCOOH ; Urine drug testing
- 刊名：International Journal of Legal Medicine
- 出版年：2016
- 出版时间：January 2016
- 年：2016
- 卷：130
- 期：1
- 页码：147-152
- 全文大小：584 KB
- 参考文献：1.United Nations Office on Drugs and Crime (2007) Annual Report 2007. UNODC, Vienna. http://www.unodc.org/documents/about-unodc/AR06_fullreport.pdf . Accessed 18 May 2015
2.Indig D, Arcuri A, Copeland J (2008) Population trends in cannabis use and first results of a study on cannabis-related emergency department presentations. Bulletin 3. National Cannabis Prevention and Information Centre, UNSW Sydney Australia. https://ncpic.org.au/professionals/publications/bulletins/bulletin-3-population-trends-in-cannabis-use-and-first-results-of-a-study-on-cannabis-related-emergency-department-presentations . Accessed 18 May 2015
3.Industrial Relations Commission of NSW (2010) Holcim (Australia) Pty Ltd v Transport Workers’ Union of NSW. Decision ([2010] NSWIRComm 1068), 23 December 2010. http://www.lawlink.nsw.gov.au/ircjudgments/2010nswircomm.nsf/f46424fdb9855ca7ca2570e60014702a/ad6bedbbfb6a4d66ca257814000253e1?OpenDocument . Accessed 18 May 2015
4.Fair Work Australia (2011) Construction, Forestry, Mining and Energy Union v HWE Mining Pty Ltd (C2009/124). Decision ([2011] FWA 8288), 30 November 2011, Melbourne Australia. https://www.fwc.gov.au/documents/decisionssigned/html/2011fwa8288.htm . Accessed 18 May 2015
5.Fair Work Commission (2015) Construction, Forestry, Mining and Energy Union v Port Kembla Coal Terminal Ltd (C2014/1370). Decision ([2015] FWC 2384), 8 April2015, Sydney Australia. https://www.fwc.gov.au/documents/decisionssigned/html/2015FWC2384.htm . Accessed 18 May 2015
6.Huestis M, Mitchell J, Cone E (1995) Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol 19:443–449PubMed CrossRef
7.Huestis M, Mitchell J, Cone E (1996) Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in humans after Single smoked doses of marijuana. J Anal Toxicol 20:441–452PubMed CrossRef
8.Lowe R, Abraham T, Darwin W, Herning R, Cadet J, Huestis M (2009) Extended urinary Δ9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend 105:24–32PubMed PubMedCentral CrossRef
9.Musshof F, Madea B (2006) Review of biological matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 28:155–163CrossRef
10.Smith-Kielland A, Skuterud B, Morland J (1999) Urinary excretion of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 23:323–332PubMed CrossRef
11.Department of Health and Human Services (2008) Federal Register Part V Mandatory Guidelines for Federal Workplace Drug Testing Programs; Notice. Substance Abuse and Mental Health Services Administration 2008. https://www.federalregister.gov/articles/2015/05/15/2015-11523/mandatory-guidelines-for-federal-workplace-drug-testing-programs . Accessed 18 May 2015
12.Standards Australia (2008) Australian Standard AS/NZS 4308:2008—procedures for specimen collection and the detection and quantitation of drugs of abuse in urine. Standards Australia, Sydney
13.Ellis G, Mann M, Judson B, Schramm N, Tashchian A (1985) Excretion of patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 38:572–578PubMed CrossRef
14.Perez-Reyes M, Di Guiseppi S, Mason A, Davis K (1983) Passive inhalation of matrihuana smoke and urinary excretion of cannabinoids. Clin Pharmacol Ther 34:36–41PubMed CrossRef
15.Elsohly M, Jones A (1995) Drug testing in the workplace: could a positive test for one of the mandated drugs be for reasons other than illicit use of the drug? J Anal Toxicol 19:450–458PubMed CrossRef
16.Manno J (1986) Interpretation of urinalysis results in urine testing for drugs of abuse. In: Hawkes R, Chiang N (eds) NIDA research monograph 73. Department of Health and Human Services, Maryland, pp 54–61
17.Huestis M, Cone E (1998) Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 22:445–454PubMed CrossRef
18.Fraser A, Worth D (2003) Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol study III. A Δ9-THC-COOH to creatinine ratio study. Forensic Sci Int 137:196–202PubMed CrossRef
19.Manno J, Ferslew K, Manno B (1984) Urine excretion patterns of cannabinoids and the clinical application of the EMIT®dau™cannabinoid urine assay for substance abuse treatment. In: Agurell S, Dewey WL, Willette R (eds) The cannabinoids: chemical pharmacologic and therapeutic aspects. Academic Press, New York, pp 281–290CrossRef
20.Goodwin R, Darwin W, Chiang CN, Shih M, Li S-H, Huestis M (2008) Urinary elimination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol 32:562–569PubMed PubMedCentral CrossRef
21.Allsop D, Norberg M, Copeland J, Fu S, Budney A (2011) The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend 119:123–129PubMed CrossRef
22.Allsop D, Copeland J, Norberg M, Fu S, Molnar A, Lewis J, Budney A (2012) Quantifying the clinical significance of cannabis withdrawal. PLoS ONE 7(9):e44864PubMed PubMedCentral CrossRef
23.Sobell LC, Sobell MB (1992) Timeline follow-back. In: Litten RZ, Allen JP (eds) Measuring alcohol consumption—psychosocial and biochemical methods. Humana Press, New York, pp 41–72CrossRef
24.Fu S, Lewis J (2008) Novel automated extraction method for quantitative analysis of urinary 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH). J Anal Toxicol 32:292–297PubMed CrossRef
25.Schwilke E, Gullberg R, Darwin W, Chiang N, Cadet J, Gorelick D, Pope H, Huestis M (2010) Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction 106:499–506PubMed PubMedCentral CrossRef
26.Johansson E, Halldin M (1989) Urinary excretion half-life of Δ1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J Anal Toxicol 13:218–223PubMed CrossRef - 作者单位：John Lewis (1) (2)
Anna Molnar (1)
David Allsop (2)
Jan Copeland (2)
Shanlin Fu (1)
1. Centre for Forensic Science, University of Technology Sydney (UTS), Broadway, Sydney, NSW, 2007, Australia
2. National Cannabis Prevention and Information Centre, UNSW Medicine, Sydney, NSW, 2052, Australia - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Forensic Medicine
Medical Law
Medicine/Public Health, general - 出版者：Springer Berlin / Heidelberg
- ISSN：1437-1596
文摘
Urinary 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (Carboxy-THC) concentrations, normalised to creatinine output, have been demonstrated to be a useful tool in the interpretation of the results of a series of urine tests for cannabis. These tests, often termed historical data, can be used to identify potential chronic cannabis users who may present occupational health and safety risks within the workplace. Conversely, the data can also be used to support employee claims of previous regular, rather than recent, cannabis use. This study aimed at examining the mean elimination of Carboxy-THC in 37 chronic users undergoing voluntary abstinence over a 2-week period. Urine specimens were collected prior to the study and after 1 and 2 weeks of abstinence. Carboxy-THC levels in urine were measured by gas chromatography–mass spectrometry (GC–MS) following alkaline hydrolysis, organic solvent extraction and derivatisation to form its pentafluoropropionic derivative. The creatinine-normalised Carboxy-THC concentrations declined rapidly over the 2 weeks of abstinence period and the majority of chronic cannabis users (73 %) reduced their urinary Carboxy-THC levels to below the 15-μg/L confirmatory cutoff within that time. The study further highlights the value of historical urinary Carboxy-THC data as a means of identifying potential occupational health and safety risks among chronic cannabis users. Keywords Cannabis Carboxy-THC THCCOOH Urine drug testing